Lataa...

Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer

SIMPLE SUMMARY: About one third of all breast cancers are classified as HER2-positive due to high levels of the HER2 cell surface protein. Drugs that target HER2 have been mostly successful, but this type of cancer returns at a high frequency once treatment has been completed. The high levels of HER...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancers (Basel)
Päätekijät: Holloway, Ryan W., Marignani, Paola A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8230691/
https://ncbi.nlm.nih.gov/pubmed/34208071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13122922
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!